{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T11:33:26Z","timestamp":1794483206699,"version":"4.9.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016806","name":"Natural Science Foundation of Nantong Municipality","doi-asserted-by":"publisher","award":["JC2023052"],"award-info":[{"award-number":["JC2023052"]}],"id":[{"id":"10.13039\/100016806","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901195"],"award-info":[{"award-number":["81901195"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.isci.2026.117833","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:30:46Z","timestamp":1791498646000},"page":"117833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting BCL11B-mediated JAK2\/STAT3 activation: A novel therapeutic strategy for Parkinson\u2019s disease"],"prefix":"10.1016","volume":"29","author":[{"given":"Wenwen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yejing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6434-7199","authenticated-orcid":false,"given":"Jiabing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.117833_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-\u03baB in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2026.117833_bib2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.mcna.2018.10.014","article-title":"Parkinson's Disease","volume":"103","author":"Reich","year":"2019","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.isci.2026.117833_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071687","article-title":"Inflammation in Parkinson's Disease: Mechanisms and Therapeutic Implications","volume":"9","author":"Pajares","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.isci.2026.117833_bib4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/glia.10161","article-title":"Microglia as a source and target of cytokines","volume":"40","author":"Hanisch","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.isci.2026.117833_bib5","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.1038\/sj.onc.1208904","article-title":"BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter","volume":"24","author":"Cismasiu","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.isci.2026.117833_bib6","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.modgep.2004.03.009","article-title":"CTIP1 and CTIP2 are differentially expressed during mouse embryogenesis","volume":"4","author":"Leid","year":"2004","journal-title":"Gene Expr. Patterns"},{"key":"10.1016\/j.isci.2026.117833_bib7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nm.1912","article-title":"Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease","volume":"15","author":"Nagahara","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.117833_bib8","doi-asserted-by":"crossref","first-page":"9751","DOI":"10.1073\/pnas.1511810112","article-title":"Huntington's disease: Neural dysfunction linked to inositol polyphosphate multikinase","volume":"112","author":"Ahmed","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.117833_bib9","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1038\/s41467-018-04111-0","article-title":"Bcl11b is essential for licensing Th2 differentiation during helminth infection and allergic asthma","volume":"9","author":"Lorentsen","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117833_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118454","article-title":"Bimin Kang ameliorates the minimal persistent inflammation in allergic rhinitis by reducing BCL11B expression and regulating ILC2 plasticity","volume":"333","author":"Qi","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.isci.2026.117833_bib11","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1212\/WNL.0b013e31828c2e9e","article-title":"Molecular and pathologic insights from latent HIV-1 infection in the human brain","volume":"80","author":"Desplats","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.isci.2026.117833_bib12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11910-022-01207-5","article-title":"Neurodegeneration and Neuroinflammation in Parkinson's Disease: a Self-Sustained Loop","volume":"22","author":"Arena","year":"2022","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.isci.2026.117833_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2023.114576","article-title":"IL-6\/JAK2\/STAT3 axis mediates neuropathic pain by regulating astrocyte and microglia activation after spinal cord injury","volume":"370","author":"Lee","year":"2023","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.isci.2026.117833_bib14","article-title":"Echinacoside Protects Dopaminergic Neurons Through Regulating IL-6\/JAK2\/STAT3 Pathway in Parkinson's Disease Model","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.isci.2026.117833_bib15","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1517\/14728220903213426","article-title":"Targeting the JAK2\/STAT3 axis in Alzheimer's disease","volume":"13","author":"Chiba","year":"2009","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.isci.2026.117833_bib16","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/kjm2.12745","article-title":"The gut microbiota metabolite butyrate mitigates MPTP\/MPP+ -induced Parkinson's disease by inhibiting the JAK2\/STAT3 signaling pathway","volume":"39","author":"Ji","year":"2023","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.isci.2026.117833_bib17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fnagi.2020.00078","article-title":"Pharmacological Inhibition of HDAC6 Attenuates NLRP3 Inflammatory Response and Protects Dopaminergic Neurons in Experimental Models of Parkinson's Disease","volume":"12","author":"Yan","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.isci.2026.117833_bib18","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","article-title":"The epidemiology of Parkinson's disease: risk factors and prevention","volume":"15","author":"Ascherio","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.isci.2026.117833_bib19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12974-022-02496-w","article-title":"The role of Toll-like receptors and neuroinflammation in Parkinson's disease","volume":"19","author":"Heidari","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.isci.2026.117833_bib20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/gbb.12287","article-title":"Structure-function integrity of the adult hippocampus depends on the transcription factor Bcl11b\/Ctip2","volume":"15","author":"Simon","year":"2016","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.isci.2026.117833_bib21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3389\/fnins.2019.00277","article-title":"Entanglement of Genetics and Epigenetics in Parkinson's Disease","volume":"13","author":"van Heesbeen","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.isci.2026.117833_bib22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2013.05.010","article-title":"Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?","volume":"140","author":"Harrison","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.isci.2026.117833_bib23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuron.2004.12.036","article-title":"Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo","volume":"45","author":"Arlotta","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.isci.2026.117833_bib24","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/jama.2014.3120","article-title":"Serum brain-derived neurotrophic factor and the risk for dementia","volume":"311","author":"Aisen","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.isci.2026.117833_bib25","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.stemcr.2019.07.015","article-title":"CTIP2-Regulated Reduction in PKA-Dependent DARPP32 Phosphorylation in Human Medium Spiny Neurons: Implications for Huntington Disease","volume":"13","author":"Fjodorova","year":"2019","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.isci.2026.117833_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102032","article-title":"Metabolic reprogramming and polarization of microglia in Parkinson's disease: Role of inflammasome and iron","volume":"90","author":"Yu","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.isci.2026.117833_bib27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jneuroim.2008.07.004","article-title":"JAK2-STAT3 signaling pathway mediates thrombin-induced proinflammatory actions of microglia in vitro","volume":"204","author":"Huang","year":"2008","journal-title":"J. Neuroimmunol."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226032141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226032141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T10:30:49Z","timestamp":1794479449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226032141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2589004226032141"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.117833","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting BCL11B-mediated JAK2\/STAT3 activation: A novel therapeutic strategy for Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.117833","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117833"}}